SCHEMBL31428565

SCHEMBL31428565

O=C(c1ccc2ncccc2c1)N1CCNCC1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.60
L3MBTL1 Q9Y468 2/20 0.59
KDM4E B2RXH2 1/20 0.59
HPGD P15428 2/20 0.56
DPP4 P27487 1/20 0.56
DPP8 Q6V1X1 1/20 0.56
MKNK1 Q9BUB5 2/20 0.52
MKNK2 Q9HBH9 2/20 0.52
RAD52 P43351 1/20 0.52
UBE2N P61088 1/20 0.52
SIGMAR1 Q99720 1/20 0.51
ALOX15 P16050 1/20 0.51
HTT P42858 1/20 0.51
PLK1 P53350 1/20 0.51
OPRD1 P41143 1/20 0.51
CCR3 P51677 1/20 0.50
MEN1 O00255 1/20 0.50
POLB P06746 1/20 0.50
KMT2A Q03164 1/20 0.50
ACACB O00763 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31043131 0.89 RIPK1 (0.60) RIPK1L3MBTL1KDM4EHPGDMKNK1
SCHEMBL6986208 0.86 HPGD (0.71) RIPK1KDM4EHPGDDPP4DPP8
SCHEMBL28256059 0.85 HPGD (0.57) HPGDDPP4DPP8MKNK1MKNK2
SCHEMBL6984876 0.84 MKNK1 (0.62) RIPK1HPGDDPP4DPP8MKNK1
SCHEMBL3296940 0.84 HPGD (0.56) HPGDDPP4DPP8MKNK1MKNK2
SCHEMBL31428718 0.83 HPGD (0.55) HPGDDPP4DPP8MKNK1MKNK2
SCHEMBL7722174 0.82 MKNK1 (0.59) RIPK1L3MBTL1KDM4EDPP4MKNK1
SCHEMBL6981541 0.82 NPC1 (0.67) HPGDDPP4DPP8ALOX15HTT
Ethylene SCHEMBL8381547 0.82 HPGD (0.54) HPGDDPP4DPP8MKNK1MKNK2
SCHEMBL30983314 0.82 MKNK1 (0.55) RIPK1HPGDDPP4DPP8MKNK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) 2025-03-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250091994-A1 RAS/RAF BINDING INHIBITOR COMPOUND BRAF, RAF1, NRAS RIPK1 546/4885L3MBTL1 1560/4885KDM4E 2663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.